位置:首页 > 蛋白库 > PILY1_PSEAW
PILY1_PSEAW
ID   PILY1_PSEAW             Reviewed;        1163 AA.
AC   S0HPF7; A8WE64;
DT   04-FEB-2015, integrated into UniProtKB/Swiss-Prot.
DT   18-SEP-2013, sequence version 1.
DT   03-AUG-2022, entry version 30.
DE   RecName: Full=Type IV pilus biogenesis factor PilY1 {ECO:0000303|PubMed:20080557};
DE   AltName: Full=Pilus-associated adhesin PilY {ECO:0000303|PubMed:20331639};
DE   Flags: Precursor;
GN   Name=pilY1 {ECO:0000312|EMBL:ABW89597.1};
GN   ORFNames=PAK_05020 {ECO:0000312|EMBL:EOT10199.1},
GN   Y880_0129235 {ECO:0000312|EMBL:KAJ87266.1};
OS   Pseudomonas aeruginosa (strain PAK).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Pseudomonadales;
OC   Pseudomonadaceae; Pseudomonas.
OX   NCBI_TaxID=1009714;
RN   [1] {ECO:0000312|EMBL:ABW89597.1}
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], X-RAY CRYSTALLOGRAPHY (2.10 ANGSTROMS)
RP   OF 615-1163 OF LEU-712/812/823-MET MUTANT IN COMPLEX WITH CALCIUM,
RP   FUNCTION, SUBCELLULAR LOCATION, DISRUPTION PHENOTYPE, MUTAGENESIS OF
RP   ASP-859, AND CIRCULAR DICHROISM.
RC   STRAIN=PAK {ECO:0000312|EMBL:ABW89597.1};
RX   PubMed=20080557; DOI=10.1073/pnas.0911616107;
RA   Orans J., Johnson M.D., Coggan K.A., Sperlazza J.R., Heiniger R.W.,
RA   Wolfgang M.C., Redinbo M.R.;
RT   "Crystal structure analysis reveals Pseudomonas PilY1 as an essential
RT   calcium-dependent regulator of bacterial surface motility.";
RL   Proc. Natl. Acad. Sci. U.S.A. 107:1065-1070(2010).
RN   [2] {ECO:0000312|EMBL:EOT10199.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=PAK {ECO:0000312|EMBL:EOT10199.1};
RG   The Broad Institute Genomics Platform;
RG   The Broad Institute Genome Sequencing Center for Infectious Disease;
RA   Hung D., Lory S., Poulsen B., Penaranda C., Ausubel F., Walker B.,
RA   Young S., Zeng Q., Gargeya S., Fitzgerald M., Haas B., Abouelleil A.,
RA   Allen A.W., Alvarado L., Arachchi H.M., Berlin A.M., Chapman S.B.,
RA   Gainer-Dewar J., Goldberg J., Griggs A., Gujja S., Hansen M., Howarth C.,
RA   Imamovic A., Ireland A., Larimer J., McCowan C., Murphy C., Pearson M.,
RA   Poon T.W., Priest M., Roberts A., Saif S., Shea T., Sisk P., Sykes S.,
RA   Wortman J., Nusbaum C., Birren B.;
RT   "The genome sequence of Pseudomonas aeruginosa PAK.";
RL   Submitted (MAY-2013) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000312|EMBL:KAJ87266.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=PAK {ECO:0000312|EMBL:KAJ87266.1};
RA   Jorth P., Whiteley M.;
RT   "Draft genome sequence of Pseudomonas aeruginosa PAK.";
RL   Submitted (DEC-2013) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   SUBCELLULAR LOCATION, AND DISRUPTION PHENOTYPE.
RC   STRAIN=PAK {ECO:0000303|PubMed:8899718};
RX   PubMed=8899718; DOI=10.1111/j.1365-2958.1996.tb02665.x;
RA   Alm R.A., Hallinan J.P., Watson A.A., Mattick J.S.;
RT   "Fimbrial biogenesis genes of Pseudomonas aeruginosa: pilW and pilX
RT   increase the similarity of type 4 fimbriae to the GSP protein-secretion
RT   systems and pilY1 encodes a gonococcal PilC homologue.";
RL   Mol. Microbiol. 22:161-173(1996).
RN   [5]
RP   FUNCTION, SUBCELLULAR LOCATION, AND DISRUPTION PHENOTYPE.
RC   STRAIN=PAK {ECO:0000303|PubMed:20331639};
RX   PubMed=20331639; DOI=10.1111/j.1462-5822.2010.01461.x;
RA   Heiniger R.W., Winther-Larsen H.C., Pickles R.J., Koomey M., Wolfgang M.C.;
RT   "Infection of human mucosal tissue by Pseudomonas aeruginosa requires
RT   sequential and mutually dependent virulence factors and a novel pilus-
RT   associated adhesin.";
RL   Cell. Microbiol. 12:1158-1173(2010).
RN   [6]
RP   FUNCTION, INTERACTION WITH HOST INTEGRINS, CALCIUM-BINDING, CIRCULAR
RP   DICHROISM, AND MUTAGENESIS OF ASP-600.
RX   PubMed=22242136; DOI=10.1371/journal.pone.0029629;
RA   Johnson M.D., Garrett C.K., Bond J.E., Coggan K.A., Wolfgang M.C.,
RA   Redinbo M.R.;
RT   "Pseudomonas aeruginosa PilY1 binds integrin in an RGD- and calcium-
RT   dependent manner.";
RL   PLoS ONE 6:E29629-E29629(2011).
CC   -!- FUNCTION: Involved in pilus assembly, twitching motility and adhesion
CC       to host cells. Primes type IV pili (T4P) assembly and is required for
CC       inclusion of minor pilins PilV, PilW and PilX to the surface pili (By
CC       similarity). Stabilizes assembled pilus fibers likely by antagonizing
CC       retraction mediated by PilT. Calcium-binding and calcium release by
CC       PilY1 seem to be essential for twitching motility and for regulation of
CC       pilus retraction dynamics of PilT. Adhesin for human tissue
CC       specifically recognizing a host receptor localized or enriched on
CC       basolateral epithelial cell surfaces. Binds host integrins in an
CC       calcium-dependent manner in vitro and this interaction may be employed
CC       by the bacterium to mediate host epithelial cell binding in vivo.
CC       {ECO:0000250|UniProtKB:Q9HVM8, ECO:0000269|PubMed:20080557,
CC       ECO:0000269|PubMed:20331639, ECO:0000269|PubMed:22242136}.
CC   -!- SUBUNIT: Interacts (via C-terminal 532-1163) with host integrins alpha-
CC       V/beta-3 (ITGAV/ITGB3) and alpha-V/beta-5 (ITGAV/ITGB5).
CC       {ECO:0000269|PubMed:22242136}.
CC   -!- SUBCELLULAR LOCATION: Fimbrium {ECO:0000269|PubMed:20080557}. Membrane
CC       {ECO:0000269|PubMed:8899718}. Cytoplasm, cytosol
CC       {ECO:0000250|UniProtKB:Q02GC2}. Note=Colocalizes with the T4P fraction
CC       when surface pili are present (PubMed:20331639, PubMed:8899718).
CC       Sheared surface fraction when PilV, PilW and PilX are also present (By
CC       similarity). {ECO:0000250|UniProtKB:Q9HVM8,
CC       ECO:0000269|PubMed:20331639, ECO:0000269|PubMed:8899718}.
CC   -!- DISRUPTION PHENOTYPE: Loss of surface T4P which is not due to the lack
CC       of major pilus structural subunit PilA (PubMed:20080557,
CC       PubMed:8899718, PubMed:20331639). Lacks measurable twitching motility
CC       (PubMed:20080557, PubMed:8899718). T4P fibers are restored when pilus
CC       retraction ATPase pilT is deleted at the same time. Does not bind to
CC       the injured regions of human ciliated airway epithelium (HAE) during
CC       bacterial infection on the contrary to the wild-type which
CC       preferentially binds to the injured regions of the HAE
CC       (PubMed:20331639). {ECO:0000269|PubMed:20080557,
CC       ECO:0000269|PubMed:20331639, ECO:0000269|PubMed:8899718}.
CC   -!- MISCELLANEOUS: Residues 600-608 comprise a calcium-binding site which
CC       together with the other one (residues 851-859) seems important for
CC       interaction with integrins of the host. {ECO:0000269|PubMed:22242136}.
CC   -!- SIMILARITY: Belongs to the PilY1 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; EU234515; ABW89597.1; -; Genomic_DNA.
DR   EMBL; ASWU01000022; EOT10199.1; -; Genomic_DNA.
DR   EMBL; AZUG01000415; KAJ87266.1; -; Genomic_DNA.
DR   RefSeq; WP_010793785.1; NZ_LR657304.1.
DR   PDB; 3HX6; X-ray; 2.10 A; A/B=615-1163.
DR   PDBsum; 3HX6; -.
DR   AlphaFoldDB; S0HPF7; -.
DR   SMR; S0HPF7; -.
DR   PATRIC; fig|1009714.6.peg.5062; -.
DR   GO; GO:0005829; C:cytosol; IEA:UniProtKB-SubCell.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0044096; C:type IV pilus; IDA:UniProtKB.
DR   GO; GO:0005509; F:calcium ion binding; IDA:UniProtKB.
DR   GO; GO:0043683; P:type IV pilus assembly; IMP:UniProtKB.
DR   GO; GO:0043107; P:type IV pilus-dependent motility; IMP:UniProtKB.
DR   InterPro; IPR008707; PilC_beta_prop_dom.
DR   InterPro; IPR011047; Quinoprotein_ADH-like_supfam.
DR   Pfam; PF05567; Neisseria_PilC; 1.
DR   SUPFAM; SSF50998; SSF50998; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Calcium; Cytoplasm; Fimbrium; Fimbrium biogenesis; Membrane;
KW   Metal-binding; Signal.
FT   SIGNAL          1..30
FT                   /evidence="ECO:0000312|EMBL:ABW89597.1"
FT   CHAIN           31..1163
FT                   /note="Type IV pilus biogenesis factor PilY1"
FT                   /evidence="ECO:0000312|EMBL:ABW89597.1"
FT                   /id="PRO_0000431917"
FT   REGION          329..352
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          619..621
FT                   /note="Integrin-binding motif RGD"
FT                   /evidence="ECO:0000303|PubMed:22242136"
FT   REGION          1138..1163
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1138..1152
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         600
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000305|PubMed:22242136"
FT   BINDING         602
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000305|PubMed:22242136"
FT   BINDING         604
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000305|PubMed:22242136"
FT   BINDING         608
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000305|PubMed:22242136"
FT   BINDING         851
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000269|PubMed:20080557"
FT   BINDING         853
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000269|PubMed:20080557"
FT   BINDING         855
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000269|PubMed:20080557"
FT   BINDING         857
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000269|PubMed:20080557"
FT   BINDING         859
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000269|PubMed:20080557"
FT   MUTAGEN         600
FT                   /note="D->A: Abolishes integrin binding and calcium binding
FT                   in the first site."
FT                   /evidence="ECO:0000269|PubMed:22242136"
FT   MUTAGEN         600
FT                   /note="D->K: Preserves integrin binding."
FT                   /evidence="ECO:0000269|PubMed:22242136"
FT   MUTAGEN         859
FT                   /note="D->A: Loss of calcium-binding. Significantly reduced
FT                   twitching motility. Dramatically reduced level of surface
FT                   T4P. Regains ability to produce normal levels of T4P and is
FT                   capable of trafficking to the T4P fraction; when associated
FT                   with pilT deletion mutant."
FT                   /evidence="ECO:0000269|PubMed:20080557"
FT   MUTAGEN         859
FT                   /note="D->K: Loss of calcium-binding. Significantly reduced
FT                   twitching motility. Insensitive to the effects of calcium
FT                   chelator EGTA and produces an abundance of non-functional
FT                   surface T4P. Capable of trafficking to the T4P fraction."
FT                   /evidence="ECO:0000269|PubMed:20080557"
SQ   SEQUENCE   1163 AA;  126248 MW;  7FCED3BE18D5FC52 CRC64;
     MKSALHQIGK TSLAAALSGA VLLSAQTTHA AALSVSQQPL MLIQGVAPNM LVTLDDSGSM
     AYAYAPDSLV NSRNNVYFAS NSYNPMYFDP NTQYKLPKKV TLSNGQIQVQ DYSKPSFTAA
     WRNGFTQEGR VNLSRDYRPT VQYQGGSGAG TESSIDWYGA PAFYYQYSGG RGCSLTTSSC
     YTRVEISGAA QQQNFANWYS FYRTRALATQ TAANLAFYSL PENARISWQL LNSSSCLIGS
     GSSNCYNNYL RDFTGQHRVN FFNWLENLSV GGGTPLRQAM TRAGEFLKKT GVNGPYAYRP
     GTQTSPEYSC RGSYHILMTD GLWNNDSASV GNADSTSRSL PDGKSYSSQT PYRDAASNTL
     ADQAFHYWAT DARPDIDDNI KPYIPYPDQA NPSAEYWNPR NDPATWQHMV TYTLGLGLTT
     SLTSPKWEGS TYSGGYDEIA AGRLSWPNAS NNHSNNVYDL WHAAVNSRGE FFSADSPDQL
     VAAFQDILNR ISGKDLPASR PAISSSLQED DTGDKLTRFA YQTSFASDKN WAGDLTRYSL
     TTQDKATVQT KLWSAQSILD AMPNGGAGRK IMMAGSGTSG LKEFTWGSLS ADQQRQLNRD
     PDRNDVADTK GQDRVAFLRG DRSKENSDNF RTRNSILGDI INSSPATVGK AQYLTYLAQP
     IEPSGNYSTF AEAQKTRAPR VYVGANDGML HGFDTDGNET FAFIPSAVFE KLHKLTARGY
     QGGAHQFYVD GSPVVADAFF GGAWHTVLIG SLRAGGKGLF ALDVTDPANI KLLWEIGVDQ
     EPDLGYSFPK PTVARLHNGK WAVVTGNGYS SLNDKAALLI IDLETGAITR KLEVTGRTGV
     PNGLSSPRLA DNNSDGVADY AYAGDLQGNL WRFDLIAGKV NQDDPFSRAN DGPAVASSFR
     VSFGGQPLYS AVDSAGAAQA ITAAPSLVRH PTRKGYIVIF GTGKYFENAD ARADTSRAQT
     LYGIWDQQTK GEAAGSTPRL TRGNLQQQTL DLQADSTFAS TARTIRIASQ NPVNWLNNDG
     STKQSGWYLD FMVNGTLKGE MLIEDMIAIG QVVLLQTITP NDDPCADGAS NWTYGLDPYT
     GGRTSFTVFD LARQGVVDSK SDYSYNKQNV AVSGTEQKGL GGLTLSTNEQ GNPEVCSSGE
     CLTVNPGPNT RGRQNWRPIE GKN
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024